Akums Drugs & Pharmaceuticals Ltd - Stock Valuation and Financial Performance

BSE: 0 | NSE: | Pharmaceuticals & Drugs | Small Cap

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Akums Drugs & Pharmaceuticals

DeciZen not available for IPO

10 Year X-Ray of Akums Drugs & Pharmaceuticals:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
ROCE % 19.3%13.6%7.1%4.8%9%9%6.6%4.5%-85.7%59.9%-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 8979675646285966837378371,1621,287564
Sales YoY Gr.-7.8%-41.6%11.3%-5.2%14.7%7.9%13.6%38.8%10.7%-
Adj EPS 8.26.63.62.55.25.73.62-27.115.40
YoY Gr.--19.7%-45.7%-30.3%111.3%9%-37.8%-42.5%-1427%NA-
BVPS (₹) 41.648.151.554.159.465.149.839.61321.80
Adj Net
Profit
10684.746.132.167.773.950.829.2-387220NAN
Cash Flow from Ops. 291683.444.171.42.8-21.855.622894-
Debt/CF from Ops. 4.60.6181.30.518.2-1.70.40.51.6-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 4.1%16.7%20.4%10.7%
Adj EPS 7.3%24%63%NA
BVPS-6.9%-18.2%-24.1%67.9%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
Return on
Equity %
21.814.67.24.79.29.26.54.6-102.988.40
Op. Profit
Mgn %
15.812.47.64.712.6125.43.2-31.218.3NAN
Net Profit
Mgn %
11.88.88.25.111.410.86.93.5-33.317.1NAN
Debt to
Equity
0.30.20.10.100.10.100.70.5-
Working Cap
Days
1962223863464064074584173554040
Cash Conv.
Cycle
73741171029288938262590

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Akums Drugs & Pharmaceuticals Ltd.

Standalone Consolidated
TTM EPS (₹) 0 -
TTM Sales (₹ Cr.) 564 -
BVPS (₹.) 0 -
Reserves (₹ Cr.) 665 -
P/BV 0.00 -
PE 0.00 -
From the Market
52 Week Low / High (₹) - / -
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) 0
Equity (₹ Cr.) 0
Face Value (₹) -
Industry PE 48.1

Management X-Ray of Akums Drugs & Pharmaceuticals:

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Akums Drugs & Pharmaceuticals

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Sales896.64966.79564.30628.14595.77683.08736.91837.441,162.061,286.83
Operating Expenses 754.67847.28521.52598.75520.53601.16696.98810.731,524.101,050.88
Manufacturing Costs31.5140.7641.5946.8139.2444.4757.8251.4972.1384.08
Material Costs608.80673.67356.60427.90360.48417.61466.35523.69768.05788.16
Employee Cost 91.67110.18102.0499.6694.16103.11123.70122.65136.37147.30
Other Costs 22.6922.6721.2824.3826.6435.9749.11112.90547.5431.35
Operating Profit 141.96119.5142.7829.4075.2481.9239.9226.70-362.04235.95
Operating Profit Margin (%) 15.8%12.4%7.6%4.7%12.6%12.0%5.4%3.2%-31.2%18.3%
Other Income 21.2937.7544.0543.0955.4856.8765.5254.5158.48102.08
Interest 8.3014.087.865.453.013.884.340.823.6513.18
Depreciation 14.3523.7122.1323.652322.8625.2626.1027.7630
Exceptional Items 00-30000-249.500-144.53
Profit Before Tax 140.60119.4853.8543.39104.71112.0575.85-195.20-334.98150.32
Tax 34.9034.859.8810.9736.9937.2124.99-49.7746.8024.89
Profit After Tax 105.6984.6443.9632.4267.7274.8450.86-145.43-381.78125.43
PAT Margin (%) 11.8%8.8%7.8%5.2%11.4%11.0%6.9%-17.4%-32.9%9.7%
Adjusted EPS (₹)8.26.63.42.55.25.83.6-10.2-26.78.8
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23

Equity and Liabilities

Shareholders Fund 537.16621.79666.06698.96767.09841.82712.32567.05185.54311.50
Share Capital 1.181.181.181.181.181.181.301.3014.3128.61
Reserves 535.98620.62664.88697.79765.92840.65711.02565.75171.23282.89
Minority Interest0000000000
Debt126.0394.1549.944733.2751.0735.8022.71122.22142.46
Long Term Debt1.51241200000021.88
Short Term Debt124.5270.1537.944733.2751.0735.8022.71122.22120.59
Trade Payables111.0657.2241.0443.4285.7368.53108.4589.87252.12177.97
Others Liabilities 77.0493.4892.0271.0174.3484.88569.69584.971,254.081,259.14
Total Liabilities 851.28866.64849.06860.39960.441,046.291,426.261,264.601,813.951,891.07

Fixed Assets

Gross Block324.27321.58335.42353.01366.54389.04416.67442.35470.08512.73
Accumulated Depreciation64.6084.27104126147.32168.88190.83213.26236.58259.59
Net Fixed Assets259.67237.31231.42227.01219.22220.16225.84229.09233.50253.15
CWIP 0000001.131.260.5216.25
Investments 4.443.9421.7821.2820.7820.2381.18149.46141.39139.16
Inventories160.8691.82120.0288.30121.36106.17122.9895.91179.31197.12
Trade Receivables191.13142.51116.32119.52121.12158.88177.69211.66303.93256.13
Cash Equivalents 21.152.012.082.890.493.8772.48125.748.85
Others Assets214.02389.05357.43401.38477.47537744.96576.23929.571,020.42
Total Assets 851.28866.64849.06860.39960.441,046.291,426.261,264.601,813.951,891.07

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Cash Flow From Operating Activity 29.03168.083.4444.0871.402.81-21.7555.57228.3194.01
PBT 140.60119.4853.8543.39104.71112.0575.85-195.20-334.98150.32
Adjustment 7.339.13-7.84-8.94-17.26-25.39-26.46-19.27-11.93-18.57
Changes in Working Capital -88.9555.5-14.4818.634.48-49.17-22.68-28.4599.58-81.51
Tax Paid -29.94-16.03-28.09-7.70-18.94-33.40-46.32-4.90-7.19-30.30
Cash Flow From Investing Activity -81.21-140.5543.86-35.32-45.92-14.78-241.71-99.96-297.96-202.17
Capex -12.71-1.41-34.12-18.43-15.05-23.23-31.01-29-28.39-103.43
Net Investments 000001.430-19.0100
Others -68.49-139.1477.99-16.89-30.877.02-210.71-51.96-269.57-98.73
Cash Flow From Financing Activity 68.77-44.20-47.24-7.95-27.8915.35301.532.6094.9989.90
Net Proceeds from Shares 000000320000
Net Proceeds from Borrowing 000-12000000
Interest Paid 0-13.85-7.75000-2.38-0.82-2.12-10.63
Dividend Paid 0000000000
Others 68.77-30.35-39.494.05-27.8915.35-16.093.4297.10100.53
Net Cash Flow 16.59-16.670.070.81-2.403.3738.07-41.7925.34-18.26
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Ratios
ROE (%)21.8314.616.834.759.249.36.54-22.73-101.4650.47
ROCE (%)25.7519.188.56.5713.8313.699.77-29.06-73.8342.75
Asset Turnover Ratio1.181.130.660.740.660.680.60.620.750.69
PAT to CFO Conversion(x)0.271.990.081.361.050.04-0.43N/AN/A0.75
Working Capital Days
Receivable Days71638368747583858179
Inventory Days55486860646157484353
Payable Days664650366567696981100

Akums Drugs & Pharmaceuticals Ltd Stock News

Akums Drugs & Pharmaceuticals Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Akums Drugs & Pharmaceuticals on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Akums Drugs & Pharmaceuticals stood at ₹0.00.
The latest P/E ratio of Akums Drugs & Pharmaceuticals as of 01-Jan-1970 05:30 is 0.00.
The latest P/B ratio of Akums Drugs & Pharmaceuticals as of 01-Jan-1970 05:30 is 0.00.
The 52-week high of Akums Drugs & Pharmaceuticals is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Akums Drugs & Pharmaceuticals is ₹564.3 ( Cr.) .

About Akums Drugs & Pharmaceuticals Ltd

No data to display
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.